ArticleCurrent cancer drug targets2013

The histone deacetylase inhibitor, MS-275 (entinostat), downregulates c-FLIP, sensitizes osteosarcoma cells to FasL, and induces the regression of osteosarcoma lung metastases.

Krithi Rao-Bindal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.